Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-19T05:47:04.906Z Has data issue: false hasContentIssue false
  • English
  • Français

Individuals developing schizophrenia are hidden among adolescent substance misusers

Published online by Cambridge University Press:  15 August 2016

S. Hodgins ,
P. Larm  and
J. Westerman
S. Hodgins*
Affiliation:
Centre de Recherche, Institut Universitaire de Santé Mentale de Montréal, Département de Psychiatrie, Université de Montréal, Montréal, Québec, H1N 3M5, Canada Department of Clinical Neuroscience, Karolinska Institute, Solna, Sweden
P. Larm
Affiliation:
Centre for Clinical Research, Uppsala University, Västmanland County Hospital Västerås and School of Health, Care and Social Welfare, Mälardalens University, Box 883, S-72123 Västerås, Sweden
J. Westerman
Affiliation:
Swedish Institute for Social Research, Stockholm University, SE-106 91 Stockholm, Sweden
*
*Address for correspondence: S. Hodgins, Département de Psychiatrie, Université de Montréal and Department of Clinical Neuroscience, Karolinska Institute Centre de Recherche, Institut Universitaire de Santé Mentale de Montréal, Montréal, Québec, H1N 3M5, Canada. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Strategies are needed to identify youth developing schizophrenia. The present study aimed to determine whether adolescents treated for substance misuse were at elevated risk to develop schizophrenia, whether this risk has changed since the late 1960s, and whether substance misuse in adolescence predicted poorer outcomes through adulthood.

Method

In a Swedish city, since the mid-1960s there has been only one clinic for adolescent substance misuse. Three samples from this clinic were studied: 1992 individuals treated from 1968 to 1971 followed to age 50 years; 1576 treated from 1980 to 1984 followed to age 35 years; and 180 treated in 2004 followed to age 22 years. Each clinical sample was matched on age, sex and place of birth to an equal, or larger, number of randomly selected individuals from the general population. Schizophrenia, substance use disorders, physical disorders related to substance misuse, criminal convictions, poverty and death were identified using national registers.

Results

Individuals treated for substance misuse in adolescence were at increased risk to subsequently develop schizophrenia: in males the increase was approximately four-fold and in females between five- and seven-fold. There was no difference in risk for those treated in 1968–1971 and from 1980 to 1984 when cannabis use increased from 37.6% to 49.8% of the clinical samples. Among males who developed schizophrenia, treatment for substance misuse was associated with increased risk of substance use disorders and criminal convictions through adulthood.

Conclusions

Treatment programmes for adolescents misusing substances include a disproportionate number developing schizophrenia. Early detection and treatment have the potential to improve long-term outcomes.

Keywords

Adolescent substance misusepsychosisschizophrenia
Type
Original Articles
Information
Psychological Medicine , Volume 46 , Issue 14 , October 2016 , pp. 3041 - 3050
Copyright
Copyright © Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Amminger, GP, Henry, LP, Harrigan, SM, Harris, MG, Alvarez-Jimenez, M, Herrman, H, Jackson, HJ, McGorry, PD (2011). Outcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study. Schizophrenia Research 131, 112–119.CrossRefGoogle ScholarPubMed
Arseneault, L (2002). Cannabis use in adolescence and risk for adult psychosis. Longitudinal prospective study. BMJ 325, 1212–1213.CrossRefGoogle ScholarPubMed
Compton, WM, Conway, KP, Stinson, FS, Colliver, JD, Grant, BF (2005). Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 66, 677–685.Google Scholar
Costello, EJ (2007). Psychiatric predictors of adolescent and young adult drug use and abuse: what have we learned? Drug and Alcohol Dependence 88 (Suppl. 1), S97–S99.Google Scholar
Di Forti, M, Vassos, E, Lynskey, M, Craig, M, Murray, RM (2015). Cannabis and psychosis – authors’ reply. Lancet Psychiatry 2, 382.CrossRefGoogle ScholarPubMed
Fazel, S, Doll, H, Långström, N (2008). Mental disorders among adolescents in juvenile detention and correctional facilities: a systematic review and metaregression analysis of 25 surveys. Journal of the American Academy of Child and Adolescent Psychiatry 47, 1010–1019.Google Scholar
Fazel, S, Långström, N, Hjern, A, Grann, M, Lichtenstein, P (2009). Schizophrenia, substance abuse, and violent crime. JAMA 301, 2016–2023.CrossRefGoogle ScholarPubMed
First, M, Gibbon, M, Spitzer, RL, Williams, JB, Benjamin, LS (1997). User's Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). American Psychiatric Press: Washington, DC.Google Scholar
First, MB, Spitzer, RL, Gibbon, M, Williams, JB (1996). User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). American Psychiatric Press: Washington, DC.Google Scholar
Gosden, NP, Kramp, P, Gabrielsen, G, Andersen, TF, Sestoft, D (2005). Violence of young criminals predicts schizophrenia: a 9-year register-based followup of 15- to 19-year-old criminals. Schizophrenia Bulletin 31, 759–768.Google Scholar
Hasin, D, Kilcoyne, B (2012). Comorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC. Current Opinion in Psychiatry 25, 165–171.Google Scholar
Hodgins, S (2008). Violent behaviour among people with schizophrenia: a framework for investigations of causes, and effective treatment, and prevention. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 363, 2505–2518.Google Scholar
Hodgins, S, Calem, M, Shimel, R, Williams, A, Harleston, D, Morgan, C, Dazzan, P, Fearon, P, Morgan, K, Lappin, J, Zanelli, J, Reichenberg, A, Jones, P (2011). Criminal offending and distinguishing features of offenders among persons experiencing a first episode of psychosis. Early Intervention in Psychiatry 5, 15–23.CrossRefGoogle ScholarPubMed
Hodgins, S, Larm, P, Molero-Samuleson, Y, Tengström, A, Larsson, A (2009). Multiple adverse outcomes over 30 years following adolescent substance misuse treatment. Acta Psychiatrica Scandinavica 119, 484–493.CrossRefGoogle ScholarPubMed
Hodgins, S, Piatosa, MJ, Schiffer, B (2014). Violence among people with schizophrenia: phenotypes and neurobiology. Current Topics in Behavioral Neurosciences 17, 329–368.Google Scholar
Hodgins, S, Tengström, A, Engström, A, Bylin, S, Göranson, M, Hagen, L, Jansson, M, Larsson, A, Lundgren-Andersson, C, Lundmark, C, Norell, E, Pedersen, H (2007). Consulting for substance abuse: mental disorders among adolescents and their parents. Nordic Journal of Psychiatry 61, 379–386.Google Scholar
Hutton, P, Parker, S, Bowe, S, Ford, S (2012) Prevalence of violence risk factors in people at ultra-high risk of developing psychosis: a service audit. Early Intervention in Psychiatry 6, 91–96.Google Scholar
Kane, JM, Robinson, DG, Schooler, NR, Mueser, KT, Penn, DL, Rosenheck, RA, Addington, J, Brunette, MF, Correll, CU, Estroff, SE, Marcy, P, Robinson, J, Meyer-Kalos, PS, Gottlieb, JD, Glynn, SM, Lynde, DW, Pipes, R, Kurian, BT, Miller, AL, Azrin, ST, Goldstein, AB, Severe, JB, Lin, H, Sint, KJ, John, M, Heinssen, RK (2016). Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. American Journal of Psychiatry 173, 362–372.Google Scholar
Kaufman, J, Birmaher, B, Brent, D, Rao, U, Flynn, C, Moreci, P, Williamson, D, Ryan, N (1997). Schedule for Affective Disorders and Schizophrenia for School-age Children – present and lifetime version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry 36, 980–988.Google Scholar
Kelleher, I, Connor, D, Clarke, MC, Devlin, N, Harley, M, Cannon, M (2012). Prevalence of psychotic symptoms in childhood and adolescence: a systematic review and meta-analysis of population-based studies. Psychological Medicine 42, 1857–1863.Google Scholar
Kinoshita, Y, Shimodera, S, Nishida, A, Kinoshita, K, Watanabe, N, Oshima, N, Tatsuo Akechi, T, Sasaki, T, Inoue, S, Furukawa, TA, Okazaki, Y (2011). Psychotic-like experiences are associated with violent behavior in adolescents. Schizophrenia Research 126, 245–251.Google Scholar
Large, MM, Nielssen, O (2011). Violence in first-episode psychosis: a systematic review and meta-analysis. Schizophrenia Research 125, 209–220.Google Scholar
Larm, P, Hodgins, S, Larsson, A, Samuelson, YM, Tengström, A (2008). Long-term outcomes of adolescents treated for substance misuse. Drug and Alcohol Dependence 96, 79–89.Google Scholar
Laurens, KR, Hodgins, S, Maughan, B, Murray, RM, Rutter, ML, Taylor, EA (2007). Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9–12 years. Schizophrenia Research 90, 130–146.Google Scholar
Ludvigsson, JF, Andersson, E, Ekbom, A, Feychting, M, Kim, J-L, Reuterwall, C, Heurgren, M, Olausson, PO (2011). External review and validation of the Swedish National Inpatient Register. BMC Public Health 11, 450.CrossRefGoogle ScholarPubMed
Malcolm, CP, Picchioni, MM, DiForti, M, Sugranyes, G, Cooke, E, Joseph, C, McQueen, G, Paparelli, A, Stilo, S, O'Connor, J, Morgan, C, Murray, RM, Hodgins, S (2011). Pre-morbid conduct disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis. Schizophrenia Research 126, 81–86.Google Scholar
Marion-Veyron, R, Lambert, M, Cotton, SM, Schimmelmann, BG, Gravier, B, McGorry, PD, Conus, P (2015). History of offending behavior in first episode psychosis patients: a marker of specific clinical needs and a call for early detection strategies among young offenders. Schizophrenia Research 161, 163–168.Google Scholar
McGrath, J, Welham, J, Scott, J, Varghese, D, Degenhardt, L, Hayatbakhsh, MR, Alati, R, Williams, GM, Bor, W, Najman, JM (2010). Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Archives of General Psychiatry 67, 440–447.Google Scholar
Power, RA, Verweij, KJH, Zuhair, M, Montgomery, GW, Henders, AK, Heath, AC, Madden, PAF, Medland, SE, Wray, NR, Martin, NG (2014). Genetic predisposition to schizophrenia associated with increased use of cannabis. Molecular Psychiatry 19, 1201–1204.Google Scholar
Purcell, R, Fraser, R, Greenwood-Smith, C, Baksheev, GN, McCarthy, J, Reid, D, Lemphers, A, Sullivan, DH (2012). Managing risks of violence in a youth mental health service: a service model description. Early Intervention in Psychiatry 6, 469–475.Google Scholar
Robins, LN, McEvoy, JP (1990). Conduct problems as predictors of substance abuse. In Straight and Devious Pathways from Childhood to Adulthood (ed. Robins, L. N. and Rutter, M.), pp. 182–204. Cambridge University Press: Cambridge, UK.Google Scholar
Swedish National Board of Health and Welfare (2014). Diagnoser i sluten vård (http://www.socialstyrelsen.se/statistik/statistikdatabas/diagnoserislutenvard). Accessed 11 November 2014.Google Scholar
Teplin, LA, Welty, LJ, Abram, KM, Dulcan, MK, Washburn, JJ (2012). Prevalence and persistence of psychiatric disorders in youth after detention: a prospective longitudinal study. Archives of General Psychiatry 69, 1031–1043.Google Scholar
Winsper, C, Singh, SP, Marwaha, S, Amos, T, Lester, H, Everard, L, Jones, P, Fowler, D, Marshall, M, Lewis, S, Sharma, V, Freemantle, N, Birchwood, M (2013). Pathways to violent behavior during first-episode psychosis: a report from the UK National EDEN Study. JAMA Psychiatry 70, 1287–1293.Google Scholar
World Health Organization (1968). International Statistical Classification of Diseases and Related Health Problems, version 8. WHO: Geneva, Switzerland.Google Scholar
World Health Organization (1978). International Statistical Classification of Diseases and Related Health Problems, version 9. WHO: Geneva, Switzerland.Google Scholar
World Health Organization (1990). International Statistical Classification of Diseases and Related Health Problems, version 10. WHO: Geneva, Switzerland.Google Scholar